Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran.
An epidemiological study to examine the sero-prevalence of zoonotic visceral leishmaniosis (ZVL) among domestic and wild canines in endemic foci of Iran was carried out during 1999-2003 to assess the distribution of the disease and the possible association between infection in dogs, wild canines and people. Anti-leishmanial antibodies were detected by the direct agglutination test (DAT). Parasitological study was performed for all captured wild canines and were detected in some of the seropositive dogs with specific clinical signs (n=107). Serum samples (n=1568) were collected from domestic dogs in villages that are known endemic foci of human visceral leishmaniosis (HVL). Wild canine sera were collected from jackals (Canis aureus, n=10), foxes (Vulpes vulpes, n=10) and wolves (Canis lupus, n=10). Of the 1568 serum sampled collected from domestic dogs, 222 (14.2%) were positive by DAT (1:320 and above). No statistically significant difference was found between male (15.2%) and female (11.8%) sero-prevalence (P=0.083). Dogs of 8 years and above showed the highest sero-prevalence (40.6%). Only 23.9% of the seropositive domestic dogs had clinical signs. Parasitology and serology tests that were performed in 30 wild canines showed 10% these animals were infected by Leishmania infantum. Ten out of 11 Leishmania spp. isolated from the dogs and wild canines were identified as L. infantum and one other as L. tropica by molecular and biochemical techniques. For the first time in Iran, L. infantum and L. tropica were isolated from viscera of both a wolf and a domestic dog.
Mohebali
Mehdi
M
School of Public Health Research, Tehran University of Medical Sciences, Department of Medical Parasitology, P.O. Box 14155-6446, Tehran, Iran. mmohebali@hotmail.com
Hajjaran
Homa
H
Hamzavi
Yazdan
Y
Mobedi
Iraj
I
Arshi
Shahnam
S
Zarei
Zabih
Z
Akhoundi
Behnaz
B
Naeini
Koroush Manouchehri
KM
Avizeh
Reza
R
Fakhar
Mehdi
M
D000372:Agglutination Tests / Q000662:veterinary; D000818:Animals; D000835:Animals, Wild / Q000469:parasitology*; D000913:Antibodies, Protozoan / Q000097:blood; D001706:Biopsy / Q000662:veterinary; D016054:DNA, Protozoan / Q000737:chemistry / Q000235:genetics; D004283:Dog Diseases / Q000453:epidemiology* / Q000469:parasitology*; D004285:Dogs; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007492:Iran / Q000453:epidemiology; D018314:Leishmania infantum / Q000254:growth & development*; D007898:Leishmaniasis, Visceral / Q000453:epidemiology / Q000469:parasitology / Q000662:veterinary*; D008297:Male; D016133:Polymerase Chain Reaction / Q000662:veterinary; D012424:Rural Population; D016036:Seroepidemiologic Studies; D013154:Spleen / Q000469:parasitology; D015047:Zoonoses / Q000453:epidemiology / Q000469:parasitology*
D000913:Antibodies, Protozoan; D016054:DNA, Protozoan